Author Archives: Emma Bonell

DDW Fall 2026

The DDW Fall 2026 issue examines precision therapies for Parkinson's Disease, what the resurgence of neuroscience means for drug discovery and why cancer vaccines depend on DNA synthesis. Other features in the Fall issue include: From investment to innovation - why we've launched a new event series The three generations of obesity medications Rethinking paediatric oncology treatments Read More

#Digital Issues

DDW Summer 2026

The DDW Summer 2026 issue examines the multi-compound approach to autism, the outlook for GLP-1 therapies and highlights drug discovery innovators and investors - investment challenges and opportunities for drug developers. Other features in the Summer issue include: The importance of tech and collaboration for immunotherapies The challenges of cancer drug resistance Where the value of AI lies in drug discovery Read More

#Digital Issues

DDW Spring 2026

The DDW Spring issue explores the next phase of obesity medications and asks how US tariffs are impacting global pharma. It also looks at how India is scaling innovation in drug discovery and includes an exclusive guide in the advancements in cancer research. Other features in the Spring issue include: Advances in genomics drug discovery Data efforts in AI Advances in radiopharmaceuticals Read More

#Digital Issues

DDW Winter 2025/2026

The DDW Winter 2025/2026 issue examines the advances and challenges in blood cancer drug development, how the Baltics is implementing a new action plan for its life sciences sectors, and how spatial epigenetics is unlocking new frontiers for drug discovery. Other features in the Winter issue include: What to expect from drug discovery in 2026 Are active immunotherapies the key to Alzheimer’s? The legal implications of AI in drug discovery Read More

#Digital Issues

DDW Fall 2025

The DDW Fall issue examines why there is a need for a universal pneumococcal vaccine, why China might be the next global biopharma powerhouse and looks at developments in microbiome research and the therapeutic sectors it is driving. It also features an exclusive guide exploring how AI is driving advancements in drug discovery. Other features in the Fall issue include: How creativity and open science are transforming drug repurposing How to harness innovation for drug discovery The promise of gene therapies in Alzheimer’s Read More

#Digital Issues

DDW Summer 2025

The DDW Summer issue includes in-depth features on the technologies and advancements driving genomics drug discovery, how supercomputing can drive neuroscience discoveries, and everything you need to know about spatial biology. Other features in the Summer issue include: A market report on the the European biotech sector How molecular precision can enable GLP-1 therapies How AI is enabling true drug design Read More

#Digital Issues

DDW Spring 2025

The DDW Spring issue explores the breakthroughs occurring in Huntington’s disease, looks at the challenges facing endometriosis drug development and highlights how quantum computing can advance drug discovery research. Other features in the Spring issue include: A market report on the US biotech hubs driving drug discovery The unmet need for fibrosis treatments and emerging treatment opportunities AI and the future of cell therapies Read More

#Digital Issues

DDW Winter 2024/2025

The DDW Winter issue asks why sex and gender need to be recognised is drug discovery, explores the drug discovery trends we’re expected to see in 2025, and features an exclusive supplement covering what’s on at SLAS2025. Other features in the Winter issue include: How to prepare for the next infectious disease pandemic Navigating the landscape of immunotherapy Pushing past the limitations of CAR-T therapies Read More

#Digital Issues

DDW Fall 2024

The DDW Fall issue asks if the gut microbiome can unlock new therapeutics for mental health disorders, places a spotlight on oncology, and includes an exclusive guide on the benefits and advances in cell line development. Other features in the Fall issue include: Beyond CRISPR–what anew tool offers gene editing How the UK could become a leader in cannabinoid research How mRNA’s tiny cousin could treat thousands of rare diseases Read More

#Digital Issues

DDW Summer 2024

The DDW Summer issue looks at where the global biotech hubs are for drug discovery and development, asks how 3D genomics can accelerate personalised medicine, and looks at the technological advances in mass spectrometry. It also includes an exclusive global cancer research guide examining the innovation happening in this sector. Read More

#Digital Issues

DDW Spring 2024

The DDW Spring issue looks at where we are in the fight against antimicrobial resistance, explores how structural biology is informing vaccine design, and offers advice on approaching dealmaking in biopharma. It also includes an exclusive cell and gene therapy guide examining the innovation happening in this sector. Read More

#Digital Issues

DDW Winter 2023/2024

The DDW Winter issue asks whether AI can deliver better immunotherapies for cancer and includes expert predictions on what to expect from the sector in 2024, alongside a supplement looking at SLAS2024 and an exclusive guide exploring therapeutic antibodies. Read More

#Digital Issues

#CAR-T #T-Cells

Quantifying T cell exhaustion: An insight into BiTE antibodies and CAR-T cells

This webinar looks at T cell exhaustion. This is recognised as a major challenge in the development of immuno-oncology therapies. Used to describe the loss of effector function due to chronic antigen exposure, it commonly occurs within the tumour microenvironment. This impairs the T cells’ ability to effectively eradicate cancerous… Read More

Webinar date:
Brought to you by Sartorius
#Webinars